Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting Inflammation in Depression Using Minocycline: a Patient Stratification Approach Using Peripheral Inflammatory Biomarkers, PET and MRI

NCT06207760 is registered in ClinicalTrials.gov with IRCCS Centro San Giovanni di Dio Fatebenefratelli as lead sponsor.

NCT NCT06207760
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06207760 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting Inflammation in Depression Using Minocycline: a Patient Stratification Approach Using Peripheral Inflammatory Biomarkers, PET and MRI
Lead sponsor
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Phase
Phase 2
Overall status
Unknown status
Start date
August 28, 2023
Completion date
April 30, 2024
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression